FDA approves Viekira Pak to treat hepatitis C

FDA has approved ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets (Viekira Pak, AbbVie) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis. » More on the fourth chronic HCV drug FDA has approved in the past 14 months

FDA grants Lucentis breakthrough therapy for diabetic retinopathy

FDA has granted breakthrough therapy designation for ranibizumab (Lucentis, Genentech) for the treatment of diabetic retinopathy.
» Read more on Lucentis

Continuing Education

MTM essentials for smoking cessation

This month's CE activity is part of a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to assist pharmacists in providing smoking cessation services for patients interested in quitting smoking..

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 14DT13-KCE28.

Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

FDA allows marketing of first newborn screening test to help detect Severe Combined Immunodeficiency

FDA has allowed marketing of the EnLite Neonatal TREC kit (PerkinElmer), the first newborn screening test for detection of Severe Combined Immunodeficiency (SCID). » Read more

• Drugs in Perspective: Sovaldi

• Drug slows diabetic retinopathy progression, but delays may limit effect

RESOURCES

Latest Clinical News